Cargando…
Study of ischemia modified albumin (IMA) as a biomarker in hypertensive retinopathy
BACKGROUND: Hypertension (HTN) is one of the leading causes of morbidity and mortality worldwide. A prompt diagnosis and treatment of hypertensive retinopathy (HR), the leading complication of HTN is pivotal for a better visual outcome. Increased blood pressure on its own cannot fully clarify the de...
Autores principales: | Pavlovschi, Ecaterina, Pantea, Valeriana, Borovic, Djina, Tagadiuc, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118206/ https://www.ncbi.nlm.nih.gov/pubmed/34013189 http://dx.doi.org/10.15386/mpr-1815 |
Ejemplares similares
-
Glutathione-related antioxidant defense system in patients with hypertensive retinopathy
por: Pavlovschi, Ecaterina, et al.
Publicado: (2021) -
A Novel Biomarker in Primary Glaucoma: Aqueous Humor and Serum Levels of Ischemia Modified Albumin (IMA)
por: Rusmayani, Emma, et al.
Publicado: (2022) -
Systemic Curcumin-Human Serum Albumin in Proliferative Vitreoretinal Retinopathy: A Pilot Study
por: Rickmann, Annekatrin, et al.
Publicado: (2021) -
Value of thiol and ischemia modified albumin (IMA) in predicting mortality in serious COVID-19 pneumonia
por: Acar, Tarik, et al.
Publicado: (2022) -
Ischemia-modified albumin (IMA) is not useful for detecting myocardial ischemia during symptom-limited exercise stress tests
por: Kim, June Hong, et al.
Publicado: (2008)